Stockreport

Cancer Vaccines Market to Hit USD 20.47 Billion by 2032 with 8.6% CAGR | MarketsandMarkets™. [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF 8.6%, reaching US$10.61 billion in 2024 and an impressive US$20.47 billion by 2032. Increased investments in research and development of neoantigen cancer vaccines and t [Read more]